Evidence map›Paper›PMID 42069659›Full record

ArticleJournal of medical case reports2026

A de novo start-loss variant in the NIPBL gene causing mild type 1 Cornelia de Lange syndrome in an Iranian family: A Case Report.

Atefeh Mir, Zahra Abbasi, Yongjun Song, Hane Lee, Ali Khajeh, Mojdeh Jahantigh, Samira Hajigholami, Shadi Khedri, Mohammad-Amin Tabatabaiefar

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Atefeh Mir *Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Zahra Abbasi *Genetics of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Yongjun SongDivision of Medical Genetics, 3billion Inc, Seoul, South Korea.
Hane LeeDivision of Medical Genetics, 3billion Inc, Seoul, South Korea.
Ali KhajehChildren and Adolescence Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Mojdeh JahantighCellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
Samira HajigholamiDepartment of Genetics and Molecular Biology, School of Medicine and Pediatric Inherited Diseases, Research Center, Research Institute for Primordial, Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran.
Shadi KhedriCellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
Mohammad-Amin TabatabaiefarDepartment of Genetics and Molecular Biology, School of Medicine and Pediatric Inherited Diseases, Research Center, Research Institute for Primordial, Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran. tabatabaiefar@med.mui.ac.ir.

Funding

Isfahan University of Medical Sciences 3991102
6 · The paper itself

Abstract

backgroundCornelia de Lange syndrome is a rare congenital disorder marked by considerable clinical variability, including intellectual disability, growth retardation, distinctive facial features, limb abnormalities, and multisystem involvement. The condition is primarily linked to mutations in genes encoding components of the cohesin complex that are essential for chromosomal stability and gene regulation. We report a case of a mild type of Cornelia de Lange syndrome caused by a de novo mutation in an Iranian family. CASE PRESENTATION: We investigated a 19-year-old Iranian male individual presenting with developmental delay, borderline intellectual disability, dysmorphic facial features, and multisystem involvement. Whole-exome sequencing was performed to identify causative variants. A de novo heterozygous variant affecting the start codon of NIPBL (NM_133433.4:c.2T>A; NP_597677.2:p.Met1Lys) was identified. This variant was absent from population databases and predicted to disrupt normal translation initiation. Sanger sequencing and co-segregation analysis confirmed the genetic findings. In silico tools and population databases were utilized to assess variant pathogenicity. Clinically, the patient exhibited classical Cornelia de Lange syndrome features with relatively mild intellectual impairment compared with typical loss-of-function cases, consistent with the hypothesis of potential use of alternative start sites.

conclusionThis case shows a known NIPBL start-loss variant's correlation with a relatively mild clinical presentation and offers more genotype-phenotype evidence for it. This finding suggests a possible role for downstream translation initiation as a modifier of disease severity, although further functional validation is required. Comprehensive genetic analysis remains essential for accurate diagnosis, prognosis, and counseling in patients with Cornelia de Lange syndrome.

Indexed as

Cell Cycle ProteinsDe Lange SyndromeIntellectual DisabilityDevelopmental DisabilitiesExome SequencingHumansIranMaleMutationPedigreeYoung AdultCell Cycle ProteinsNIPBL protein, humanCornelia de Lange syndromeNIPBLWhole-exome sequencing

Identifiers

PMID42069659
PMCPMC13285449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.